Gültige Versionsangaben für medizinische Klassifikationen

10 2004 GM

ICD 10 Version 2004 GM

10 2004 WHO

ICD 10 Version 2004 WHO

10 2005 GM

ICD 10 Version 2005 GM

10 2005 WHO

ICD 10 Version 2005 WHO

10 2006 GM

ICD 10 Version 2006 GM

10 2006 WHO

ICD 10 Version 2006 WHO (gültig bis 2010)

10 2007 GM

ICD 10 Version 2007 GM

10 2008 GM

ICD 10 Version 2008 GM

10 2009 GM

ICD 10 Version 2009 GM

10 2010 GM

ICD 10 Version 2010 GM

10 2011 GM

ICD 10 Version 2011 GM

10 2011 WHO

ICD 10 Version 2011 WHO (gültig bis 2012)

10 2012 GM

ICD 10 Version 2012 GM

10 2013 GM

ICD 10 Version 2013 GM

10 2013 WHO

ICD 10 Version 2013 WHO (gültig bis 2015)

10 2014 GM

ICD 10 Version 2014 GM

10 2015 GM

ICD 10 Version 2015 GM

10 2016 GM

ICD 10 Version 2016 GM

10 2016 WHO

ICD 10 Version 2016 WHO (gültig bis 2018)

10 2017 GM

ICD 10 Version 2017 GM

10 2018 GM

ICD 10 Version 2018 GM

10 2019 GM

ICD 10 Version 2019 GM

10 2019 WHO

ICD 10 Version 2019 WHO (letzte Version, wird nur noch in Ausnahmefällen aktualisiert)

10 2020 GM

ICD 10 Version 2020 GM

10 2021 GM

ICD 10 Version 2021 GM

10 2022 GM

ICD 10 Version 2022 GM

10 2023 GM

ICD 10 Version 2023 GM

Sonstige

Falls andere bzw. ältere Versionen verwendet werden

31

ICD-O-3, 2003

32

ICD-O-3, 1. Revision 2014

33

ICD-O-3, 2. Revision 2019

bb

Neue Codes aus den WHO-Klassifikationen (BlueBooks)

6

6. Auflage

7

7. Auflage

8

8. Auflage

2004

Version 2004

2005

Version 2005

2006

Version 2006

2007

Version 2007

2008

Version 2008

2009

Version 2009

2010

Version 2010

2011

Version 2011

2012

Version 2012

2013

Version 2013

2014

Version 2014

2015

Version 2015

2016

Version 2016

2017

Version 2017

2018

Version 2018

2019

Version 2019

2020

Version 2020

2021

Version 2021

2022

Version 2022

2023

Version 2023

2024

Version 2024

2025

Version 2025

2026

Version 2026

2027

Version 2027

2028

Version 2028

2029

Version 2029

4

Version 4

4.03

Version 4.03

5.0

Version 5.0

Sonstige

Falls andere bzw. ältere Versionen verwendet werden

ICD-O

Definiton WHO Classification

Version

ICD-O-3 Topographie

Meldepflicht ICD-10
(D-Diagnosen)

Quelle
Buch
Online-Zugang

Seite(n)

8144/2

Intestinal-type Adenoma, high grade

BB

C16.-
C17.-
C24.1

D00.2
D01.4
D01.5

WHO Classification of Tumours Editorial Board. Digestive System tumours. Lyon (France): International Agency for Research on Cancer; 2019. (WHO classification of tumours series, 5th ed.; vol. 1)

76, 118, 121

8211/2

Tubular adenoma, high grade

BB

C18.- (ohne C18.1)
C19.9
C20.9

D01.0
D01.1
D01.2

WHO Classification of Tumours Editorial Board. Digestive System tumours. Lyon (France): International Agency for Research on Cancer; 2019. (WHO classification of tumours series, 5th ed.; vol. 1)

170

8213/2

Serrated dysplasia, high grade

BB

C16.-
C17.-
C18.-
C19.9
C20.9

D00.2
D01.4
D01.0
D01.1
D01.2

WHO Classification of Tumours Editorial Board. Digestive System tumours. Lyon (France): International Agency for Research on Cancer; 2019. (WHO classification of tumours series, 5th ed.; vol. 1)

71, 118, 141, 163

8271/3

Lactotroph PitNET/adenoma 

BB

C75.1

-

WHO Classification of Endocrine and Neuroendocrine Tumorours (5th ed.) online//Pituitary tumours//Anterior pituitary neuroendocrine tumours (PitNETs)//PitNETs of PIT1 lineage//Lactotroph PitNET/adenoma 

-

8290/1

Spindle cell oncocytoma /Oncocytic pituicytoma

BB

C75.1

D44.3

WHO Classification of Endocrine and Neuroendocrine Tumorours (5th ed.) online//Pituitary tumours//Posterior pituitary and hypothalamic neoplasms//Pituicyte-derived tumours//Pituicytomas 

-

8455/2

Intraductal oncocytic papillary neoplasm NOS

BB

C25.-

D01.7

WHO Classification of Tumours Editorial Board. Digestive System tumours. Lyon (France): International Agency for Research on Cancer; 2019. (WHO classification of tumours series, 5th ed.; vol. 1)

315

8455/3

Intraductal oncocytic papillary neoplasm NOS with associated invasive carcinoma

BB

C25.-

-

WHO Classification of Tumours Editorial Board. Digestive System tumours. Lyon (France): International Agency for Research on Cancer; 2019. (WHO classification of tumours series, 5th ed.; vol. 1)

315

8480/2

Low-grade appendiceal mucinous neoplasm

BB

C18.1

D01.0

WHO Classification of Tumours Editorial Board. Digestive System tumours. Lyon (France): International Agency for Research on Cancer; 2019. (WHO classification of tumours series, 5th ed.; vol. 1)

144

8480/2

High-grade appendiceal mucinous neoplasm

BB

C18.1

D01.0

WHO Classification of Tumours Editorial Board. Digestive System tumours. Lyon (France): International Agency for Research on Cancer; 2019. (WHO classification of tumours series, 5th ed.; vol. 1)

144

8483/2

Adenocarcinoma in situ, HPV-associated

BB

C53.-

D06.-

WHO Classification of Tumours Editorial Board. Female Genital Tumours. Lyon (France): International Agency for Research on Cancer; 2020. (WHO classification of tumours series, 5th ed.; vol. 4)

364

8483/3

Adenocarcinoma, HPV-associated

BB

C52.9
C53.-

-

WHO Classification of Tumours Editorial Board. Female Genital Tumours. Lyon (France): International Agency for Research on Cancer; 2020. (WHO classification of tumours series, 5th ed.; vol. 4)

367, 407

8484/2

Adenocarcinoma in situ, HPV-independent

BB

C53.-

D06.-

WHO Classification of Tumours Editorial Board. Female Genital Tumours. Lyon (France): International Agency for Research on Cancer; 2020. (WHO classification of tumours series, 5th ed.; vol. 4)

372

8484/3

Adenocarcinoma, HPV-independent, NOS

BB

C53.-

-

WHO Classification of Tumours Editorial Board. Female Genital Tumours. Lyon (France): International Agency for Research on Cancer; 2020. (WHO classification of tumours series, 5th ed.; vol. 4)

380

8683/3

Gangliocytic paraganglioma

BB

C17.0
C24.1

Selten:
C15.-
C16.4
C17.1
C18.1
C25.-
C34.-
C37.9

-

WHO Classification of Endocrine and Neuroendocrine Tumours (5th ed.) online//Neuroendocrine neoplasms in non-endocrine organs //Neuroendocrine neoplasms //Paraganglioma-like neuroendocrine neoplasms //Composite gangliocytoma/neuroma and neuroendocrine tumour 

-

8859/3

Myxoid pleomorphic liposarcoma

BB

C38.3
C49.-

-

WHO Classification of Tumours Editorial Board. Soft tissue and bone tumours. Lyon (France): International Agency for Research on Cancer; 2020. (WHO classification of tumours series, 5th ed.; vol. 3)

47

9050/2

Mesothelioma in situ

BB

C38.4
C48.2

D09.7

WHO Classification of Tumours Editorial Board. Thoracic Tumours. Lyon (France): International Agency for Research on Cancer; 2021. (WHO classification of tumours series, 5th ed.; vol. 5)

200

9061/2

Intratubular seminoma, Intratubular trophoblast

BB

C62.-

D07.6

WHO Classification of Urinary and Male Genital Tumours (5th ed.) online//Tumours of the testis//Germ cell tumours derived from germ cell neoplasia in situ// Non-invasive germ cell neoplasia//Specific forms of intratubular germ cell neoplasia 

-

9070/2

Intratubular embryonal carcinoma

BB

C62.-

D07.6

WHO Classification of Urinary and Male Genital Tumours (5th ed.) online//Tumours of the testis//Germ cell tumours derived from germ cell neoplasia in situ// Non-invasive germ cell neoplasia//Specific forms of intratubular germ cell neoplasia 

-

9071/2

Intratubular yolk sac tumour

BB